|
Planning & Projects |
Commercial |
Rosetta Building
Construction
Start: November 2002
Occupied: March 2004
-
4-story, 136,000 SF biotech building
-
New home of Rosetta Inpharmatics
(wholly owned by Merck)
-
Rosetta discovers and develops
medicines to treat cancer, diabetes, Alzheimer's disease and more
-
Schnitzer Northwest is development
partner
|